| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,230,000 |
| Market
Cap: |
303.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.8 - $14.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,735 |
21,833 |
25,311 |
165,018 |
| Total Sell Value |
$18,442 |
$258,319 |
$292,764 |
$385,800 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
9 |
20 |
37 |
63 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stuglik Brian M |
Chief Executive Officer |
• • – |
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
371,000 |
|
- |
|
| Ridgeback Capital Management Llc |
10% Owner |
– – • |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,515,151 |
10,068,243 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,604,651 |
|
-55% |
|
| Stuglik Brian M |
Chief Executive Officer |
• • – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
270,000 |
270,000 |
|
- |
|
| Gagnon Robert E. |
Chief Financial Officer |
• – – |
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
151,000 |
|
- |
|
| Barberich Timothy J |
Director |
– • – |
2019-03-15 |
4 |
B |
$3.21 |
$105,930 |
D/D |
33,000 |
168,000 |
2.39 |
- |
|
| Barberich Timothy J |
Director |
– • – |
2018-09-28 |
4 |
B |
$7.31 |
$36,550 |
D/D |
5,000 |
135,000 |
2.39 |
- |
|
| Paterson Dan |
Chief Operating Officer |
• – – |
2018-09-28 |
4 |
B |
$7.00 |
$21,000 |
D/D |
3,000 |
23,286 |
2.74 |
- |
|
| Stuglik Brian M |
Director |
– • – |
2018-09-28 |
4 |
B |
$7.30 |
$7,303 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| Kauffman Michael |
Director |
– • – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
8,000 |
|
- |
|
| Kauffman Michael |
Director |
– • – |
2018-09-28 |
4 |
B |
$7.49 |
$29,960 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| Forrester Robert |
President and CEO |
• • – |
2018-09-28 |
4 |
B |
$7.00 |
$14,000 |
D/D |
2,000 |
221,234 |
2.81 |
- |
|
| Lobacki Joseph M |
Executive VP & CCO |
• – – |
2018-09-28 |
4 |
B |
$7.30 |
$21,900 |
D/D |
3,000 |
10,700 |
2.74 |
- |
|
| Paterson Dan |
Chief Operating Officer |
• – – |
2018-09-27 |
4 |
B |
$7.01 |
$14,056 |
D/D |
2,000 |
20,286 |
2.74 |
- |
|
| Forrester Robert |
President and CEO |
• • – |
2018-09-27 |
4 |
B |
$7.00 |
$73,500 |
D/D |
10,500 |
219,234 |
2.81 |
- |
|
| Gagnon Robert E. |
Chief Financial Officer |
• – – |
2018-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,000 |
|
- |
|
| Bloom Steven H. |
Chief Strategy Officer |
• – – |
2018-06-08 |
4 |
B |
$5.98 |
$17,940 |
D/D |
3,000 |
3,500 |
2.74 |
- |
|
| Lobacki Joseph M |
Executive VP & CCO |
• – – |
2018-06-08 |
4 |
B |
$5.79 |
$44,583 |
D/D |
7,700 |
7,700 |
2.74 |
- |
|
| Barberich Timothy J |
Director |
– • – |
2017-12-05 |
4 |
B |
$3.95 |
$239,125 |
D/D |
60,538 |
130,000 |
2.39 |
- |
|
| Rowinsky Eric K |
Director |
– • – |
2017-09-05 |
4 |
B |
$3.84 |
$7,680 |
I/I |
2,000 |
2,000 |
2.1 |
- |
|
| Barberich Timothy J |
Director |
– • – |
2017-05-15 |
4 |
B |
$2.45 |
$73,500 |
D/D |
30,000 |
69,462 |
2.39 |
- |
|
| Chiapponi Joseph |
Vice President of FinanceOffic |
• – – |
2016-04-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,502 |
|
- |
|
| Kauffman Michael |
Director |
– • – |
2015-08-24 |
4 |
S |
$6.46 |
$13,374 |
D/D |
(2,070) |
0 |
|
- |
|
| Paterson Dan |
Chief Operating Officer |
• – – |
2015-08-01 |
4 |
D |
$7.30 |
$46,392 |
D/D |
(6,355) |
18,286 |
|
- |
|
| Forrester Robert |
President & CEO |
• • – |
2015-08-01 |
4 |
D |
$7.30 |
$59,787 |
D/D |
(8,190) |
218,734 |
|
- |
|
168 Records found
|
|
Page 5 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.17 (1.43%) 
